The Foolies are out in force with another ad for their flagship Stock Advisor newsletter, we’re on vacation this week so I’m not putting together brand new articles but I reminded you about their “#1 Stock Across the Motley Fool Universe” yesterday … and today we’ll remind you about the other pick they’re pitching in […]
Articles
- Most Relevant
- Most Recent
I’ve had a bunch of readers asking me to look at the ads for Chris Mayer’s new service, so that’s the plan today. We don’t usually see ads for newsletters that cite Stock Gumshoe, so that also helped catch my eye when I was browsing ads and deciding which teaser pitch to cover recently — […]
Pain management is a huge market in the medical world, as you’re no doubt aware — and buckets of money are pouring down on the many, many little biotech stocks who are trying to develop new pain medications, or to tweak existing medications to make them safer or less likely to be abused. So it’s […]
[ed note: Michael Jorrin is longtime medical writer who has been sharing his thoughts with our readers as “Doc Gumshoe” for several years (he’s not a doctor, I gave him the name). He generally covers medical and health news and sometimes health promotions and hype, but he rarely opines about investments or specific stocks. All of his past […]
The last time Dr Al Sears crossed our path, his banner headline was that President Obama, “the most corrupt president in U. S. history,” issued a “Death Order” in 2016 that “could result in the needless deaths of 1.3 million American seniors this year.” That “Death Order” consisted in the appointment of Robert Califf, […]
I got a few requests to take a look at the “better restaurant stock” that Timothy Lutts of Cabot alluded to in his recent article about Chipotle (CMG), and one of those readers pointed out that one of the other stocks that Cabot has been teasing, LeMaitre Vascular (LMAT), “has been looking good” … so […]
This tease comes in an ad for the Motley Fool’s Global Gains newsletter, which has brought some interesting ideas to our attention during its relatively short life so far (though I imagine it probably had a terrible year last year — this is one of the few Motley Fool newsletters that Hulbert doesn’t track, and […]
The Oxford Club has been recruiting subscribers by dangling the promise of their “$3 Secret Stock” for almost a year now, and those ads are still rolling around the interwebs… but it looks like they’ve finally got a new recruitment tool: The “Next American Mega-Brand.” So what is it? Let’s check out the ad, see […]
As with many past promotions from the folks at Cabot’s Stock of the Month newsletter, they’re comparing their new pick to First Solar, and guaranteeing that the shares will double in a matter of months (or your money back … and yes, that’s the subscription money, not the money you might have lost on the […]
. DescriptionDescription Dear Reader, Hello. My name is Joe Schriefer. Today I’m going to show you a LIVE demonstration of a mysterious and misunderstood financial maneuver/transaction that could generate hundreds of dollars in INSTANT INCOME in three minutes or less. I’ve made it my personal mission to show you that absolutely anyone can generate INSTANT […]
Dave Lashmet has been a biotech/medical analyst and sometimes a newsletter editor at Stansberry for a long time, and the latest iteration of his high-end newsletter is now called Stansberry Venture Technology (currently “on sale” for $2,500, no refunds)… and it’s now being promoted with a “cure for cancer” spiel, so we obviously all want […]
During these crazy market moves, a lot of us are keeping in the back of our mind a notion along the lines of, “hey, this might be the chance to buy something cheap… but it better be really, really good!” And for many of us, that means our minds drift to “blue chip” type stocks […]
Stansberry & Associates’ Phase 1 Investor newsletter is teasing us about shares of a drug company: “On March 30, FDA results we’ve waited 2 years to receive could make you $195,600, overnight” — and they quote Porter Stansberry as saying that “This is the kind of situation that can change your life… where a $10,000 stake can allow you to literally quit work, forever.” Sounds nice, eh?
Tom Dyson at the Palm Beach Letter has generally been a relatively low-risk, income-focused guy — he used to run the 12% Letter for Stansberry, before starting Palm Beach Letter with Mark Ford a couple years ago, and for a newsletter guy he does relatively little of the “swing for the fences” stuff. Not that […]
[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]
This counts as a “holy crap!” week when it comes to earnings, not because of any huge reporting that moved the market but because of the surge by just one stock, our fad retailer Five Below (FIVE) after earnings on Wednesday night. FIVE is generally lumped into the “dollar store” category, it’s the teen-focused retailer […]
[ed. note: Michael Jorrin, who I like to call Doc Gumshoe, writes mostly non-financial articles about health topics for our readers a couple times a month — he is not a doctor (he’s a longtime medical writer), he chooses his own topics, and his words and opinions are his own. Enjoy!] It was only a […]
That quote in our headline comes from Bret Jensen, who runs the Blue Chip Gems newsletter put out by Investors Alley (he also has a Biotech Gems letter and a Small Cap Gems letter, with sector focus that you can probably guess at by their titles). We’ve looked at a couple of stocks he has […]
Robert Hsu is having an easier time selling his service these days, I imagine — things were pretty quiet on the teaser front for his China Strategy newsletter when China was in full-fledged stock market collapse, but the remarkable bounceback from those lows this year has made us all love the Middle Kingdom again (even […]
“Is it really possible to safely make $5,500 or more, in cash, in the next 24 hours?” That’s how they open this teaser for a new investment newsletter from Stansberry and Associates, called Jeff Clark’s Advanced Income. And just as an aside, duh, of course you can safely make $5,500 or more in 24 hours […]
Excerpt: And one company that’s 350x smaller than Apple is front and center, manufacturing these components that could unlock this $7 trillion gold rush.
February 10, 2021 / backoffice
what’s Chris Rowe’s Biden Boom that should drive down electricity costs
and put many electric buyers out of business.Thanks Travis
It is supposed to with over 3 Trillion dollars over 7 to 8 years, that is possibly blockchain technology.Thanks Travis
Anyone Know what stock and (separately) what drug/compound Angel Reserve is touting for an Anti-Aging miracle? Were that true, not sure which would make me more excited…the ability to buy the stock or take the drug. Thanks team appreciate any insight.
I bought $1000 of TSLA at $85 for my kids college fund – he starts college 2029. Just put a trailing stop on it at 15%. Smart or dumb? I appreciate your thoughts.
Hi All. How do think this will effect TSLA and the semi conductor stocks? https://www.bbc.com/news/technology-55936011
I’m interested in views on John Hussman’s negative prophesies for the markets. He’s been negative for a while now but his arguments in his latest missive seem powerful: https://www.hussmanfunds.com/comment/mc210201/
Hi guys, I really want to start learning to understand more about stock numbers. I am very new to investing and following mostly gumshoes advice but I don’t actually understand the numbers or strategy behind it. How can I learn more about the decision making? A friend of me has followed a 3 day workshop […]
There Was a post about CloudMD a Canadian company a few days back it seems to have disappeared or maybe I do not know where to look. But I am wondering if anyone had taken a look at it and what your thoughts were. thanks
It’s about invisible detection. From Jason Simpkins.
Would be helpful if Travis would put a date on each review. Then looking back we could quickly see how the stock did.
Has anyone tried investing in Ourcrowd.com? I’ve been looking on the companies posted on their website, seems like minimum investment is $10,000. Most of this companies are startup. I’ve been planning to try investing on start up or pre IPO stocks. Anyone knows a better investment company or any tips on what good startup company […]
If the answer to those two questions should turn out to be an unequivocal “Yes!” that would definitely be cause for champagne and fireworks. Sorry to say that for now, at least, we have to put the champagne and fireworks on hold. But, who knows, might there be something – a few snippets […]
This article was originally posted on August 27, when we first saw these ads circulating… apparently lots of folks missed it, and the ads are running hot and heavy again, so we’re re-posting it here to help answer a flood of new reader questions. The stock teased has popped 40-50% or so on the Stansberry […]
I saved this teaser pitch to cover for you, dear Irregulars… and I confess that it’s mostly because covering a company this tiny and illiquid for our larger group of free readers feels a little bit irresponsible. Even if I say cynical or skeptical things about a stock, talking to thousands of my closest friends […]
A version of this article was originally published on October 21, 2019, but the ad continues to circulate and generate new questions so we have updated it to address any changes over the past six months. Hard to believe that the major publishers didn’t already have something called The Penny Stock Letter, but this is […]
The plan for today? Figure out what other name might be associated with Nikola Tesla, and use it as the name for a new-age company. Venture funding should flow without regard to merit, and you might just be able to go straight to an IPO and buy that private island. Nikola (NKLA) is taken, thanks […]
So currently we are working on the short term 5G, sell-driving vehicles, AI/DL/ML, and electric vehicles.I have strong interest in Blockchain, financial privacy (I am tired of being taxed 5 times for every dollar and for even investments in Crypto). But also it provides a OpenBanking, OpenTrading. Crypto is not just ’coins’ the Blockchain is […]
So currently we are working on the short term 5G, sell-driving vehicles, AI/DL/ML, and electric vehicles.I have strong interest in Blockchain, financial privacy (I am tired of being taxed 5 times for every dollar and for even investments in Crypto). But also it provides a OpenBanking, OpenTrading. Crypto is not just ’coins’ the Blockchain is […]
So currently we are working on the short term 5G, sell-driving vehicles, AI/DL/ML, and electric vehicles.I have strong interest in Blockchain, financial privacy (I am tired of being taxed 5 times for every dollar and for even investments in Crypto). But also it provides a OpenBanking, OpenTrading. Crypto is not just ’coins’ the Blockchain is […]